HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randomised crossover trial of naltrexone in uraemic pruritus.

AbstractBACKGROUND:
Most dialysis patients develop pruritus, for which current treatment is unsatisfactory. Endogenous opioids may be involved in this pruritus. We studied the effect of the opioid antagonist naltrexone on the pruritus of haemodialysis patients.
METHODS:
Naltrexone 50 mg per day by mouth was given to 15 haemodialysis patients with severe resistant pruritus in a randomised, double-blind, placebo-controlled crossover trial. The naltrexone or placebo periods lasted 7 days each with a 7-day washout between the two periods. Pruritus was assessed by the patients on a visual analogue scale from 0 (no pruritus) to 10 (maximum), and mean daily scores were calculated. Plasma histamine and beta-endorphin levels were measured, and spontaneous and stimulated basophil histamine-release were determined.
FINDINGS:
The median pruritus scores at the end of the naltrexone treatment were 2.1 (interquartile range 1.5-2.15) for the naltrexone-placebo sequence and 1.0 (0.4-1.15) for the placebo-naltrexone sequence. The respective values before naltrexone was given were 9.9 (9.85-9.95) and 9.9 (9.3-10.0). Plasma beta-endorphin levels were normal and remained unchanged during the study. Plasma histamine levels were high (mean 2.32 [SD 0.11] ng/mL, normal < 1.0) and decreased after naltrexone (to 1.8 [0.09], p < 0.01). Basophils from haemodialysis patients stimulated by interleukin-3 plus IgE antibodies released high amounts of histamine. The increase was 78.3 (19.3)% compared with 26.6 (16.3)% for five normal controls (p < 0.01). Incubation of the basophils with naloxone, another opioid antagonist, prevented this effect.
INTERPRETATION:
Our data suggest short-term efficacy with few side-effects for the amelioration of uraemic pruritus with naltrexone.
AuthorsG Peer, S Kivity, O Agami, E Fireman, D Silverberg, M Blum, A laina
JournalLancet (London, England) (Lancet) Vol. 348 Issue 9041 Pg. 1552-4 (Dec 07 1996) ISSN: 0140-6736 [Print] England
PMID8950882 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Narcotic Antagonists
  • Naltrexone
  • beta-Endorphin
  • Histamine
Topics
  • Cross-Over Studies
  • Double-Blind Method
  • Histamine (blood)
  • Humans
  • Naltrexone (therapeutic use)
  • Narcotic Antagonists (therapeutic use)
  • Pruritus (blood, drug therapy, etiology)
  • Renal Dialysis
  • Uremia (blood, complications, therapy)
  • beta-Endorphin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: